Envisagenics’ artificial intelligence wows real investors
By GREGORY ZELLER // They’re on a major roll at Envisagenics Inc., a Cold Spring Harbor Laboratory spinoff that’s piling up some hefty research grants. Now based in New York…
Biotech
How to speak cytokine: a bioelectronics breakthrough
By GREGORY ZELLER // You can bet they didn’t use secret decoder rings. In a major feat of bioengineering and neurological science, a team of doctors at Northwell Health’s Feinstein…
Grant backs NYU Winthrop’s out-of-the-skull thinking
By GREGORY ZELLER // A “surprise grant” from the Alzheimer’s Disease Resource Center will further some promising Alzheimer’s-related research underway at NYU Winthrop Hospital. The Mineola hospital’s Research Institute announced…
Memo to Applied DNA: It’s payday in Pennsylvania
By GREGORY ZELLER // Memorandums of understanding are swell and all, but for a scrappy enterprise forever waging a bottom-line battle, nothing beats getting paid. So, Stony Brook-based Applied DNA…
Applied DNA won’t let the bed thugs bite
By GREGORY ZELLER // You’ll sleep better knowing your gorgeous new bedding comes from 100 percent source-verified recycled plastic. So say global textiles manufacturer GHCL Ltd. and Applied DNA Sciences,…
Long-lasting glaucoma fix? They can see it from here
By GREGORY ZELLER // A Stony Brook biotech looking to carve a nanotech niche in the science of glaucoma treatment is eyeing some impressive laboratory results. Sustained Nano Systems, working…
Applied DNA journeys deeper into India, and pharma
By GREGORY ZELLER // A new professional collaboration will deepen a Long Island biotech’s ties with global pharmaceutical and nutraceutical manufacturers. Stony Brook-based Applied DNA Sciences has signed a memorandum…
NIH backs SBU-based biotech’s tuberculosis effort
By GREGORY ZELLER // A Setauket-based pharmaceuticals startup specializing in biomarker analysis has landed a chunky National Institutes of Health research award. Chronus Pharmaceuticals, founded and managed by researchers representing…
Smoking-hot biotech sparks key cannabis contract
By GREGORY ZELLER // It’s another new high for Applied DNA Sciences. Just days after introducing a new satellite laboratory in India to service its growing Asian-Pacific customer base, the…
For Applied DNA, a lucrative new passage to India
By GREGORY ZELLER // Growing interest from Asian-Pacific textile manufacturers has prompted a Long Island biotech to establish a new testing laboratory in India. Stony Brook-based Applied DNA Sciences on…
Applied DNA catches Irish robber blue/green-handed
By GREGORY ZELLER // Already the bane of Swedish car thieves, Applied DNA Sciences has now notched its first armed-robbery criminal conviction in Ireland. The latest international adventure for the…
Missiles, cars, leather … finally, biotech pushes pills
By GREGORY ZELLER // A biotech with a penchant for leather, foreign automobiles, high-tech weaponry and next-gen digital imaging is finally getting around to pharmaceuticals. Actually, that’s not true –…
CSHL conference lands a bull’s eye on Lyme detection
By GREGORY ZELLER // A gaggle of academic, public health and commercial-healthcare specialists gathered under Cold Spring Harbor Laboratory’s mighty banner have published findings that could rewrite the book on…
Applied DNA is talking Turkey (and West Africa, too)
By GREGORY ZELLER // Applied DNA Sciences is in one of those modes again: another week, another big leap into a potentially lucrative geographic or vertical market. This week, it’s…
As biopharma blossoms, ace DNA producer locks in
By GREGORY ZELLER // Applied DNA Sciences has long proclaimed textiles – your cotton shirt, your leather shoes and the industries that produce them – as its primary vertical market,…